Startseite Crystal structure of 4-(2,2-difluoroethyl)-2,4,6-trimethylisoquinoline-1,3(2H,4H)-dione, C14H15F2NO2
Artikel Open Access

Crystal structure of 4-(2,2-difluoroethyl)-2,4,6-trimethylisoquinoline-1,3(2H,4H)-dione, C14H15F2NO2

  • Huixing Li ORCID logo EMAIL logo , Xinlong Han und Bin Cao
Veröffentlicht/Copyright: 21. Januar 2021

Abstract

C14H15F2NO2, monoclinic, P21/c (no. 14), a = 11.5474(10) Å, b = 11.0737(7) Å, c = 11.4311(10) Å, β = 114.979(11)°, V = 1325.0(2) Å3, Z = 4, Rgt(F) = 0.0738, wRref(F2) = 0.2034, T = 293(2) K.

CCDC no.: 2054639

The molecular structure is shown in the Figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Colourless block
Size:0.23 × 0.20 × 0.18 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.11 mm-1
Diffractometer, scan mode:D8-APEX2, φ and ω
θmax, completeness:27.8°, 99%
N(hkl)measuredN(hkl)uniqueRint:7513, 2688, 0.036
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 1886
N(param)refined:274
Programs:Bruker [1], Olex2 [2], SHELX [3]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
C1a0.3381 (4)0.2220 (3)0.6764 (4)0.0424 (9)
C1Ab0.309 (2)0.2344 (18)0.7149 (18)0.063 (4)
C20.1206 (3)0.2426 (3)0.5044 (3)0.0499 (7)
C30.14746 (19)0.36866 (16)0.48370 (19)0.0438 (6)
C4a0.26464 (17)0.4227 (2)0.5567 (2)0.0374 (9)
C4Ab0.2437 (19)0.4292 (19)0.5913 (18)0.063 (5)
C5a0.3726 (3)0.3513 (3)0.6581 (3)0.0370 (7)
C5Ab0.3353 (17)0.3682 (15)0.7129 (15)0.061 (3)
C6a0.4896 (7)0.3449 (8)0.6261 (6)0.0507 (12)
H6Aa0.5563420.2993400.6916330.076*
H6Ba0.5195850.4251030.6227340.076*
H6Ca0.4657120.3062110.5439930.076*
C6Ab0.329 (3)0.456 (3)0.823 (4)0.069 (7)
H6AAb0.2510670.5016180.7881070.104*
H6ABb0.4005310.5106500.8520320.104*
H6ACb0.3323020.4085800.8945320.104*
C70.05091 (15)0.43441 (18)0.38855 (18)0.0563 (7)
H7−0.0274830.3982380.3396920.068*
C80.0715 (2)0.55423 (18)0.3664 (2)0.0588 (8)
H8Aa0.0069410.5982230.3027560.071*
H8Bb0.0198460.5899920.2879920.071*
C9a0.1887 (3)0.60829 (18)0.4394 (3)0.0490 (15)
C9Ab0.1726 (18)0.6245 (17)0.464 (2)0.048 (4)
C10a0.2853 (2)0.5425 (2)0.5346 (3)0.0471 (11)
H10a0.3636630.5787140.5834480.056*
C10Ab0.2533 (17)0.5515 (18)0.564 (2)0.063 (5)
H10Ab0.3258530.5902110.6235660.075*
C11a0.2099 (8)0.7392 (6)0.4190 (10)0.075 (2)
H11Aa0.2038570.7500530.3332550.113*
H11Ba0.2931190.7634420.4806880.113*
H11Ca0.1461020.7875170.4298350.113*
C11Ab0.183 (4)0.760 (3)0.440 (5)0.090 (10)
H11Db0.2596370.7740470.4285230.136*
H11Eb0.1852640.8052060.5119430.136*
H11Fb0.1102370.7838170.3630680.136*
C12a0.4183 (3)0.4144 (3)0.7916 (3)0.0417 (8)
H12Aa0.4825320.3644690.8564230.050*
H12Ba0.4579190.4908910.7884530.050*
C12Ab0.4682 (18)0.3829 (15)0.7371 (19)0.074 (4)
H12Cb0.5215380.3327960.8094610.088*
H12Db0.4937140.4664030.7587450.088*
C13a0.3088 (9)0.4373 (9)0.8314 (9)0.0568 (12)
H13a0.2479330.4933670.7695020.068*
C13Ab0.488 (5)0.342 (5)0.603 (5)0.107 (6)
H13Ab0.4382190.3832080.5209890.129*
C140.1886 (4)0.0518 (3)0.6244 (4)0.0773 (11)
H14A0.239775−0.0013540.5992000.116*
H14B0.0998290.0347410.5736100.116*
H14C0.2087310.0396990.7140900.116*
F1a0.2497 (3)0.3426 (3)0.8359 (3)0.0807 (9)
F1Ab0.6286 (14)0.3575 (16)0.6669 (19)0.155 (7)
F2a0.3601 (3)0.4912 (3)0.9509 (3)0.0985 (11)
F2Ab0.4822 (15)0.2247 (13)0.6108 (16)0.126 (5)
N10.2156 (2)0.1779 (2)0.6035 (2)0.0538 (6)
O1a0.4173 (4)0.1580 (4)0.7576 (4)0.0680 (11)
O1Ab0.379 (2)0.1726 (18)0.8021 (18)0.112 (8)
O20.0203 (2)0.1934 (2)0.4379 (2)0.0784 (8)
  1. aOccupancy: 0.788 (4), bOccupancy: 0.212 (4).

Source of material

According to the literature method [4], the title compound was obtained in 72% yield. The title compound was recrystallized from anhydrous tetrahydrofuran at room temperature to obtain the colorless block crystals.

Experimental details

All H atoms were located by geometrical calculations and refined as riding atoms, and their positions and thermal parameters were fixed during the structure refinement. Some atoms are disordered over two positions. The two parts overlapped each other with site occupation factors of 0.788 and 0.212. The disorder is omitted in the figure for clarity.

Comment

Isoquinoline-1,3-dione and its derivatives have been widely investigated due to their excellent pharmaceutical and biological activities, such as anti-tumor and HIV-1 integrase inhibitors [5], [6], [7], [8], [9], [10]. Especially, the isoquinoline-1,3-diones containing a difluoromethyl moiety (CF2H) often show special biological properties [4], [11], [12]. However, the synthesis and crystal structure of difluoromethylated isoquinoline-1,3-diones remains limited. In order to investigate the structural and biological properties of difluoromethylated isoquinoline-1,3-diones, the structure of the title compound was analyzed in detail.

In the asymmetric unit of the crystal structure, the C=O bond lengths of 1.218(5) and 1.213(3) Å show typical double-bond character. The central six-membered ring [C1/N1/C2/C3/C4/C5] is slightly deviated from planarity, the mean deviation from the plane of 0.0225 Å (see the Figure). The deviation of N1 is the highest, 0.0344 Å. In the crystal structure, the molecules are linked into three-dimensional frameworks by weak C—H⋯F and C—H⋯O hydrogen bonds. All geometric parameters may be slightly affected by the diorder in this structure.


Corresponding author: Huixing Li, Henan Key Laboratory of Industrial Microbial Resources and Fermentation Technology, Nanyang Institute of Technology, 473004, Nanyang, Henan, People’s Republic of China; and School of Biological and Chemical Engineering, Nanyang Institute of Technology, 473004, Nanyang, Henan, People’s Republic of China, E-mail:

Award Identifier / Grant number: 182300410151

Funding source: Scientific and Technological Project of Henan Province

Award Identifier / Grant number: 162102210114

Award Identifier / Grant number: 17A610003

Funding source: Henan Key Laboratory of Industrial Microbial Resources and Fermentation Technology Open Project

Award Identifier / Grant number: HIMFT20200206

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: Natural Science Foundation of Henan Province of China (182300410151), Scientific and Technological Project of Henan Province (162102210114), Key Scientific Research Project of College and University in Henan Province (17A610003) and Henan Key Laboratory of Industrial Microbial Resources and Fermentation Technology Open Project (HIMFT20200206).

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Bruker. APEX2, SAINT and SADABS; Bruker AXS Inc.: Madison, Wisconsin, USA, 2008.Suche in Google Scholar

2. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Suche in Google Scholar

3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Suche in Google Scholar

4. Zou, G., Wang, X. Visible-light induced di- and trifluoromethylation of N-benzamides with fluorinated sulfones for the synthesis of CF2H/CF3-containing isoquinolinediones. Org. Biomol. Chem. 2017, 15, 8748–8754; https://doi.org/10.1039/c7ob02226c.Suche in Google Scholar

5. Hua, M.-Q., Mou, F.-Y., Wang, N.-H., Chen, Y., Xiong, H.-Y., Huang, Y., Lei, C.-L., Zhang, Q. Visible-light-induced photocatalytic difluoroalkylation of 3-substituted benzo[d]isoxazoles via direct and regioselective C-H functionalization. Tetrahedron Lett. 2018, 59, 4449–4453; https://doi.org/10.1016/j.tetlet.2018.10.007.Suche in Google Scholar

6. Vernekar, S. K. V., Liu, Z., Nagy, E., Miller, L., Kirby, K. A., Wilson, D. J., Kankanala, J., Sarafianos, S. G., Parniak, M. A., Wang, Z. Design, synthesis, biochemical, and antiviral evaluations of C6 benzyl and C6 biarylmethyl substituted 2-hydroxylisoquinoline-1,3-diones: dual inhibition against HIV reverse transcriptase-associated RNase H and polymerase with antiviral activities. J. Med. Chem. 2015, 58, 651–664; https://doi.org/10.1021/jm501132s.Suche in Google Scholar

7. Cai, C. W., Lomonosova, E., Moran, E. A., Cheng, X., Patel, K. B., Bailly, F., Cotelle, P., Meyers, M. J., Tavis, J. E. Hepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activity. Antivir. Res. 2014, 108, 48–55; https://doi.org/10.1016/j.antiviral.2014.05.007.Suche in Google Scholar

8. Billamboz, M., Suchaud, V., Bailly, F., Lion, C., Demeulemeester, J., Calmels, C., Andréola, M.-L., Christ, F., Debyser, Z., Cotelle, P. 4-Substituted 2-hydroxyisoquinoline-1,3(2H,4H)-diones as a novel class of HIV-1 integrase inhibitors. ACS Med. Chem. Lett. 2013, 4, 606–611; https://doi.org/10.1021/ml400009t.Suche in Google Scholar

9. Chen, Y.-L., Tang, J., Kesler, M. J., Sham, Y. Y., Vince, R., Geraghty, R. J., Wang, Z. The design, synthesis and biological evaluations of C-6 or C-7 substituted 2-hydroxyisoquinoline-1,3-diones as inhibitors of hepatitis C virus. Bioorg. Med. Chem. 2012, 20, 467–479; https://doi.org/10.1016/j.bmc.2011.10.058.Suche in Google Scholar

10. Wang, S., Dai, P., Yan, Z., Wang, Y., Shao, J., Wu, Y., Deng, C., Zhang, W. Metal-free, visible-light-induced radical trifluoromethylation/cyclization of N-benzamides with CF3SO2Na to synthesize CF3-containing isoquinoline-1,3-diones. ChemistrySelect 2019, 4, 10329–10333; https://doi.org/10.1002/slct.201902545.Suche in Google Scholar

11. Koike, T. Frontiers in radical fluoromethylation by visible-light organic photocatalysis. Asian J. Org. Chem. 2020, 9, 529–537; https://doi.org/10.1002/ajoc.202000058.Suche in Google Scholar

12. Hu, W.-Q., Xu, X.-H., Qing, F.-L. Visible light induced hydrodifluoromethylation of alkenes derived from oxindoles with (difluoromethyl)triphenylphosphonium bromide. J. Fluor. Chem. 2018, 208, 73–79; https://doi.org/10.1016/j.jfluchem.2018.01.013.Suche in Google Scholar

Received: 2020-12-18
Accepted: 2021-01-08
Published Online: 2021-01-21
Published in Print: 2021-05-26

© 2021 Huixing Li et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. The crystal structure of bis(μ2-5-chloro-2-oxido-N-(1-oxidoethylidene)benzohydrazonato-κ5N,O,O′:N′,O′′)hexkis(pyridine-κ1N)trinickel(II) - pyridine (1/1), C63H57Cl2N13Ni3O6
  4. Crystal structure of [(μ2-succinato κ3O,O′:O′′)-bis-(5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane)]dinickel(II)] diperchlorate, dihydrate C36H82Cl2N8Ni2O15
  5. Crystal structure of catena-poly[aquabis(3-nitrobenzoato-κ2O:O′)-(μ2-pyrazine-N: N′)cadmium(II)], C18H14N4O9Cd
  6. Crystal structure of 4-(2,2-difluoroethyl)-2,4,6-trimethylisoquinoline-1,3(2H,4H)-dione, C14H15F2NO2
  7. The crystal structure of thioxanthen-9-one-10,10-dioxide, C13H8O3S – a second polymorph
  8. Crystal structure of (E)-2-((2-methoxy-3-pyridyl)methylene)-7-fluoro-3,4-dihydronaphthalen-1(2H)-one, C17H14FNO2
  9. The crystal structure of diaquahydrogen 2,5-dimethylbenzenesulphonate, C8H14O5S
  10. The crystal structure of N-(4-(cyclohexylimino)pent-2-en-2-yl)cyclohexanamine, C17H30N2
  11. The twinned crystal structure of 1,3-phenylenedimethanaminium dibromide, C8H14Br2N2
  12. Crystal structure of 2,4,7,9-tetranitro-10H-benzofuro[3,2-b]indole – dimethyl sulfoxide (1/1), C16H11N5O10S
  13. Crystal structure of 2,6-bis(2-(pyridin-3-yl)ethyl)pyrrolo[3,4-f]isoindole-1,3,5,7(2H,6H)-tetraone, C24H18N4O4
  14. The crystal structure of 3,4-dichlorobenzoic acid chloride, C7H3Cl3O
  15. Crystal structure of 1,1′-(1,4-phenylenebis(methylene))bis(pyridin-1-ium) bis(1,2-dicyanoethene-1,2-dithiolato-k2S:S)zinc(II), C26H18N6ZnS4
  16. Crystal structure of tetrakis(μ-naphthalene-1-carboxylato-κ2O,O′)bis(methanol)copper(II), C46H36Cu2O10
  17. Crystal structure of 9-methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one, C14H13NO
  18. Crystal structure of bis(amino(carbamothioylamino)methaniminium) 3-nitrophthalate monohydrate, C12H19N9O7S2
  19. Crystal structure of 3,3′-(1,2-phenylene-bis(methylene))bis(1-ethyl-1H-imidazol-3-ium) bis(hexafluorophosphate), C18H24F12N4P2
  20. The crystal structure of 5-hydroxy-6,8-dimethoxy-2-methyl-4H-benzo[g]chromen-4-one– rubrofusarin B, C16H14O5
  21. The crystal structure of bis(ethanol-kO)- bis(6-aminopicolinato-k2N,O)manganese(II), C16H22O6N4Mn
  22. The crystal structure of 3,3′-((carbonylbis(azanediyl))bis(ethane-2,1-diyl)) bis(1-methyl-1H-benzo[d]imidazol-3-ium) tetrafluoroborate monohydrate, C21H28N6O3B2F8
  23. Crystal structure of dimethanol-dichlorido-bis( μ2-2-(((1,5-dimethyl-3-oxo-2- phenyl-2,3-dihydro-1H-pyrazol-4-yl)imino)methyl)phenolato- κ4O:O,O′,N)dinickel (II), C20H24ClNiN3O4
  24. The crystal structure of methyl 5-(trifluoromethyl)-1H-pyrrole-2-carboxylate, C7H6F3NO2
  25. Crystal structure of (OC‐6‐13)‐aqua‐tris (3‐bromopyridine‐κ1N)‐bis(trifluoroacetato‐κ1O)cadmium(II) C19H14Br3CdF6N3O5
  26. Crystal structure of methyl (E)-3-(4-(2-ethoxy-2-oxoethoxy)phenyl) acrylate, C14H16O5
  27. Crystal structure of methyl 4-acetoxy-3,5-dimethoxybenzoate, C12H14O6
  28. The crystal structure of 2-(1H-benzimidazol-2-yl)-3-bromo-5-chlorophenol, C13H8BrClN2O
  29. The crystal structure of bis(μ2-5-chloro-N-(2-methyl-1-oxidopropylidene)-2-oxidobenzohydrazonate-κ5N,O,O′:N′,O′′)pentakis(pyridine-κ1N)tricopper(II), C47H45Cl2N9Cu3O6
  30. Synthesis and crystal structure of catena-poly[aqua-bis(nitrato-κ2O:O′)- (μ2-((1 H-imidazol-1-yl)methyl)benzene-κ2 N,N′)-H2O-κ2O]cadmium(II), C14H16N6O7Cd
  31. The crystal structure of pentakis(carbonyl)-{μ-[2,3-bis(sulfanyl)propan-1-olato]}-(triphenylphosphane)diiron (FeFe)C26H21Fe2O6PS2
  32. Crystal structure of ethyl-2-(3-benzoylthioureido)propanoate, C13H16N2O3S
  33. Crystal structure of 2-methoxy-4b,5,14,15-tetrahydro-6H-isoquinolino[2′,1′:1,6] pyrazino[2,3-b]quinoxaline, C19H18N4O
  34. Crystal structure of 2,2′-[ethane-1,2-diylbis(azanylylidenemethylylidene)]bis(6-chlorophenol), C16H14Cl2N2O2
  35. The crystal structure of (Z)-3-((2-(2-(2-aminophenoxy)ethoxy)phenyl)amino)-1-phenylbut-2-en-1-one, C24H24N2O3
  36. The crystal structure of 10-(3,5-di(pyridin-4-yl)phenyl)-10H-phenoxazine dihydrate, C28H23N3O3
  37. Crystal structure of poly[dipoly[aqua-di(µ2-pyrazin-2-olato-κ2N:N′) zinc(II)], C8H8N4O3Zn
  38. Crystal structure of poly[tetra(μ2-cyanido-κ2N:O)-bis(N,N-dimethylformamide-κO)-manganese(II)-platinum(II)], C10H14MnN6O2Pt
  39. The crystal structure of aqua-chlorido-6,6′-((ethane-1,2-diylbis(azaneylylidene))bis(methaneylylidene))bis(2,4-dichlorophenolato-κ4N,N′,O,O′)manganese(III), C16H12Cl5MnN2O3
  40. Crystal structure of [di(µ2-cyanido)-dicyanido-bis(dimethyl sulfoxide-κO)- bis(2,2′-(ethane-1,2-diylbis(azanylylidenemethanylylidene))diphenolato-κ4,N,N′,O,O′)- dimanganese(III)-platinum(II)], C40H40Mn2N8O6PtS2
  41. The crystal structure of (azido)-κ1N-6,6′-((cyclohexane-1,2-diylbis(azanylylidene)) bis(methanylylidene))bis(3-bromophenolato-κ4N,N,O,O)-(methanol)-manganese(III)–methanol(1/1), C22H26Br2MnN5O4
  42. Crystal structure of 7-chloro-N-(4-iodobenzyl)-1,2,3,4-tetrahydroacridin-9-amine, C20H18ClIN2
  43. Crystal structure of catena-poly[(1,4,8,11-tetraazacyclotetradecane-κ4N,N,N,N′′′)-bis(μ2-thiocyanato-κ2N:S)-bis(thiocyanato-κS)-nickel(II)palladium(II)], C14H24N8NiPdS4
  44. Crystal structure of 3-chloro-4-(4-ethylpiperazin-1-yl)aniline monohydrate, C12H20ClN3O
  45. Crystal structure of the 2D coordination polymer poly[diaqua-bis(μ2-3- methoxyisonicotinato-κ2N:O)cobalt(II)] — dimethylformamide (1/1), C20H30CoN4O10
  46. Crystal structure of 4-[(5-chloro-2-hydroxybenzylidene)amino]-3-propyl-1H-1,2,4-triazole-5(4H)-thione, C12H13ClN4OS
  47. Crystal structure of N-(5-(2-(benzyl(1-(4-methoxyphenyl)propan-2-yl)amino)-1-hydroxyethyl)-2-(benzyloxy)phenyl)formamide, C33H36N2O4
  48. Crystal structure of 3-(methoxycarbonyl)-7-oxabicyclo[2.2.1]heptane-2-carboxylic acid, C9H12O5
  49. The crystal structure of 1-((dimethylamino)(3-nitrophenyl)methyl)naphthalen-2-ol, C19H18N2O3
  50. Crystal structure of catena-poly[di(μ2-cyanido-κ2C:N)-dicyanido-tetrakis(dimethyl sulfoxide-κO)-manganese(II)-platinum(II)], C12H24MnN4O4PtS4
  51. Crystal structure of 4-amino-N-(2-pyrimidinyl)benzenesulfonamide–1,4-dioxane (1/1), C14H18N4O4S
  52. Crystal structure of bis{1-[(benzotriazol-1-yl)methyl]-1H-1,3-(2-methyl-imidazol)}di-chloridomercury(II), [Hg(C11H11N5)2Cl2], C22H22N10Cl2Hg
  53. Crystal structure of 2, 3-bis((4-methylbenzoyl)oxy) succinic acid–N, N-dimethylformamide (1/1), C23H25NO9
  54. Crystal structure of catena-poly[bis(4-(4-carboxyphenoxy)benzoato-κ1O)-μ2-(1,4-bis(1-imidazolyl)benzene-κ2N:N′)cobalt(II)], C40H28N4O10Co
  55. Crystal structure of 1H-imidazol-3-ium poly[aqua-(μ4-glutarato-κ6O,O′:O′:O′′,O′′′:O′′′)-(nitrato-κ2O,O′)strontium(II)], C8H13N3O8Sr
  56. Crystal structure of (R)-6-(benzo[b]thiophen-5-yl)-2-methyl-2,6-dihydrobenzo [5,6] silino[4,3,2-cd]indole, C23H17NSSi
  57. Crystal structure of catena-poly[bis(μ2-thiocyanato-κ2N:S)-(2-(5-methyl-1H-pyrazol-3-yl)pyridine-κ2N,N′)cadmium(II)]–dioxane (1/1), C15H17CdN5O2S2
  58. Crystal structure of poly[aqua-(μ2-1,4-bis(2′-carboxylatophenoxy)benzene-κ2O:O′)-(μ2-4,4′-bipyridione-κ2N:N′)cadmium(II)] monhydrate, C30H22CdN2O7⋅H2O
  59. Crystal structure of catena-poly[tetraaqua-(μ2-4,4′-bipyridine-k2N:N′)-bis(μ2-4′-methyl-[1,1′-biphenyl]-3,5-dicarboxylato-k4O,O′:O″,O′″)dicadmium(II)] dihydrate, C20H20NO7Cd
  60. Crystal structure of 1‐tert‐butyl‐3‐(2,6‐diisopropyl‐4‐phenoxyphenyl)‐2-methylisothiourea, C24H34N2OS
  61. Crystal structure of catena-poly[triaqua-(μ2-1,3-di(1H-imidazol-1-yl)propane-κ2N:N′)-(4,4′-(1H-1,2,4-triazole-3,5-diyl)dibenzoato-κ1O)cobalt(II)] — N,N′-dimethylformamide (1/1), C28H34N8O8Co
  62. Crystal structure of tetraaqua-bis(1,4-di(1H-imidazol-1-yl)benzene-κ1N)manganese(II) 2,3-dihydroxyterephthalate, C32H32MnN8O10
Heruntergeladen am 22.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2020-0635/html
Button zum nach oben scrollen